APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Safety Assessment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Safety Assessment Market Analysis and Forecast 2026-2032

3 May 2026200 pages

Choose your research edition.

Industry ResearchPharmaceutical Safety Assessment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Safety Assessment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Safety Assessment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Safety Assessment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Safety Assessment Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Safety Assessment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Safety Assessment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Safety Assessment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Safety Assessment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Safety Assessment include Eurofins, LabCorp, Fujifilm Wako, Charles River, SGS, Intertek Group, CTI, Frontage and Medicilon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Safety Assessment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Safety Assessment, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Safety Assessment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Safety Assessment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Safety Assessment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Safety Assessment revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Safety Assessment Segment by Company

Eurofins

LabCorp

Fujifilm Wako

Charles River

SGS

Intertek Group

CTI

Frontage

Medicilon

Wuxi Biologics

Pharmaron

Pharmaceutical Safety Assessment Segment by Type

Biological Drugs

Chemical Drugs

Pharmaceutical Safety Assessment Segment by Application

Clinical

Non-clinical

Pharmaceutical Safety Assessment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Safety Assessment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Safety Assessment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Safety Assessment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Safety Assessment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Safety Assessment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Safety Assessment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biological Drugs Major Player Table 3. Chemical Drugs Major Player Table 4. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Major Player Table 6. Non-clinical Major Player Table 7. Pharmaceutical Safety Assessment Industry Trends Table 8. Pharmaceutical Safety Assessment Industry Drivers Table 9. Pharmaceutical Safety Assessment Industry Opportunities and Challenges Table 10. Pharmaceutical Safety Assessment Industry Restraints Table 11. Global Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Pharmaceutical Safety Assessment Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Pharmaceutical Safety Assessment Market Share by Region (2021-2026) Table 14. Global Pharmaceutical Safety Assessment Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Pharmaceutical Safety Assessment Market Share by Region (2027-2032) Table 16. Global Pharmaceutical Safety Assessment Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Pharmaceutical Safety Assessment Revenue Market Share by Players (2021-2026) Table 18. Global Pharmaceutical Safety Assessment Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Pharmaceutical Safety Assessment Key Players Headquarters & Area Served Table 20. Global Pharmaceutical Safety Assessment Players, Product Type & Application Table 21. Global Pharmaceutical Safety Assessment Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Pharmaceutical Safety Assessment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Pharmaceutical Safety Assessment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Safety Assessment Revenue Market Share by Type (2021-2026) Table 28. Global Pharmaceutical Safety Assessment Revenue Market Share by Type (2027-2032) Table 29. Global Pharmaceutical Safety Assessment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2021-2026) Table 33. Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2027-2032) Table 34. Eurofins Company Information Table 35. Eurofins Business Overview Table 36. Eurofins Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Eurofins Pharmaceutical Safety Assessment Product Portfolio Table 38. Eurofins Recent Development Table 39. LabCorp Company Information Table 40. LabCorp Business Overview Table 41. LabCorp Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. LabCorp Pharmaceutical Safety Assessment Product Portfolio Table 43. LabCorp Recent Development Table 44. Fujifilm Wako Company Information Table 45. Fujifilm Wako Business Overview Table 46. Fujifilm Wako Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Fujifilm Wako Pharmaceutical Safety Assessment Product Portfolio Table 48. Fujifilm Wako Recent Development Table 49. Charles River Company Information Table 50. Charles River Business Overview Table 51. Charles River Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Charles River Pharmaceutical Safety Assessment Product Portfolio Table 53. Charles River Recent Development Table 54. SGS Company Information Table 55. SGS Business Overview Table 56. SGS Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SGS Pharmaceutical Safety Assessment Product Portfolio Table 58. SGS Recent Development Table 59. Intertek Group Company Information Table 60. Intertek Group Business Overview Table 61. Intertek Group Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Intertek Group Pharmaceutical Safety Assessment Product Portfolio Table 63. Intertek Group Recent Development Table 64. CTI Company Information Table 65. CTI Business Overview Table 66. CTI Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. CTI Pharmaceutical Safety Assessment Product Portfolio Table 68. CTI Recent Development Table 69. Frontage Company Information Table 70. Frontage Business Overview Table 71. Frontage Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Frontage Pharmaceutical Safety Assessment Product Portfolio Table 73. Frontage Recent Development Table 74. Medicilon Company Information Table 75. Medicilon Business Overview Table 76. Medicilon Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Medicilon Pharmaceutical Safety Assessment Product Portfolio Table 78. Medicilon Recent Development Table 79. Wuxi Biologics Company Information Table 80. Wuxi Biologics Business Overview Table 81. Wuxi Biologics Pharmaceutical Safety Assessment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Wuxi Biologics Pharmaceutical Safety Assessment Product Portfolio Table 83. Wuxi Biologics Recent Development Table 84. Pharmaron Company Information Table 85. Pharmaron Business Overview Table 86. Pharmaron Pharmaceutical Safety Assessment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Pharmaron Pharmaceutical Safety Assessment Product Portfolio Table 88. Pharmaron Recent Development Table 89. North America Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Pharmaceutical Safety Assessment Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Pharmaceutical Safety Assessment Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Pharmaceutical Safety Assessment Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Pharmaceutical Safety Assessment Revenue by Country (US$ Million) & (2027-2032) Table 103. China Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 104. China Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 105. China Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 106. China Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Pharmaceutical Safety Assessment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Pharmaceutical Safety Assessment Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Pharmaceutical Safety Assessment Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Pharmaceutical Safety Assessment Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Pharmaceutical Safety Assessment Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Pharmaceutical Safety Assessment Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Pharmaceutical Safety Assessment Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Pharmaceutical Safety Assessment Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Pharmaceutical Safety Assessment Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Pharmaceutical Safety Assessment Image Figure 2. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Safety Assessment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biological Drugs Image Figure 5. Chemical Drugs Image Figure 6. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmaceutical Safety Assessment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Image Figure 9. Non-clinical Image Figure 10. Global Pharmaceutical Safety Assessment Market Size (US$ Million) & (2021-2032) Figure 11. Global Pharmaceutical Safety Assessment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Safety Assessment Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Safety Assessment Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Pharmaceutical Safety Assessment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical Safety Assessment Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Safety Assessment Revenue Market Share by Type (2021-2032) Figure 18. Global Pharmaceutical Safety Assessment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2021-2032) Figure 21. North America Pharmaceutical Safety Assessment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032) Figure 23. North America Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032) Figure 24. North America Pharmaceutical Safety Assessment Revenue Share by Country (2021-2032) Figure 25. United States Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Pharmaceutical Safety Assessment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032) Figure 30. Europe Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032) Figure 31. Europe Pharmaceutical Safety Assessment Revenue Share by Country (2021-2032) Figure 32. Germany Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Pharmaceutical Safety Assessment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032) Figure 42. China Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032) Figure 43. Asia Pharmaceutical Safety Assessment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032) Figure 45. Asia Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Safety Assessment Revenue Share by Region (2021-2032) Figure 47. Japan Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Pharmaceutical Safety Assessment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032) Figure 55. SAMEA Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032) Figure 56. SAMEA Pharmaceutical Safety Assessment Revenue Share by Country (2021-2032) Figure 57. Brazil Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Pharmaceutical Safety Assessment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Biological Drugs
  • Chemical Drugs
Applications
  • Clinical
  • Non-clinical
Companies covered
  • Eurofins
  • LabCorp
  • Fujifilm Wako
  • Charles River
  • SGS
  • Intertek Group
  • CTI
  • Frontage
  • Medicilon
  • Wuxi Biologics
  • Pharmaron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Safety Assessment Market by Type
  3. 1.2.1 Global Pharmaceutical Safety Assessment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biological Drugs
  5. 1.2.3 Chemical Drugs
  6. 1.3 Pharmaceutical Safety Assessment Market by Application
  7. 1.3.1 Global Pharmaceutical Safety Assessment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical
  9. 1.3.3 Non-clinical
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Pharmaceutical Safety Assessment Market Dynamics
  1. 2.1 Pharmaceutical Safety Assessment Industry Trends
  2. 2.2 Pharmaceutical Safety Assessment Industry Drivers
  3. 2.3 Pharmaceutical Safety Assessment Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Safety Assessment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Safety Assessment Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Safety Assessment Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Safety Assessment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Safety Assessment Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Safety Assessment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Safety Assessment Revenue by Players
  2. 4.1.1 Global Pharmaceutical Safety Assessment Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Safety Assessment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Safety Assessment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Safety Assessment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Safety Assessment Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Safety Assessment Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Safety Assessment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Safety Assessment Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Safety Assessment Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Safety Assessment Market Size by Type
  1. 5.1 Global Pharmaceutical Safety Assessment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Safety Assessment Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Safety Assessment Market Size by Application
  1. 6.1 Global Pharmaceutical Safety Assessment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins
  2. 7.1.1 Eurofins Company Information
  3. 7.1.2 Eurofins Business Overview
  4. 7.1.3 Eurofins Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Pharmaceutical Safety Assessment Product Portfolio
  6. 7.1.5 Eurofins Recent Developments
  7. 7.2 LabCorp
  8. 7.2.1 LabCorp Company Information
  9. 7.2.2 LabCorp Business Overview
  10. 7.2.3 LabCorp Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 LabCorp Pharmaceutical Safety Assessment Product Portfolio
  12. 7.2.5 LabCorp Recent Developments
  13. 7.3 Fujifilm Wako
  14. 7.3.1 Fujifilm Wako Company Information
  15. 7.3.2 Fujifilm Wako Business Overview
  16. 7.3.3 Fujifilm Wako Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fujifilm Wako Pharmaceutical Safety Assessment Product Portfolio
  18. 7.3.5 Fujifilm Wako Recent Developments
  19. 7.4 Charles River
  20. 7.4.1 Charles River Company Information
  21. 7.4.2 Charles River Business Overview
  22. 7.4.3 Charles River Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Pharmaceutical Safety Assessment Product Portfolio
  24. 7.4.5 Charles River Recent Developments
  25. 7.5 SGS
  26. 7.5.1 SGS Company Information
  27. 7.5.2 SGS Business Overview
  28. 7.5.3 SGS Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SGS Pharmaceutical Safety Assessment Product Portfolio
  30. 7.5.5 SGS Recent Developments
  31. 7.6 Intertek Group
  32. 7.6.1 Intertek Group Company Information
  33. 7.6.2 Intertek Group Business Overview
  34. 7.6.3 Intertek Group Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intertek Group Pharmaceutical Safety Assessment Product Portfolio
  36. 7.6.5 Intertek Group Recent Developments
  37. 7.7 CTI
  38. 7.7.1 CTI Company Information
  39. 7.7.2 CTI Business Overview
  40. 7.7.3 CTI Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CTI Pharmaceutical Safety Assessment Product Portfolio
  42. 7.7.5 CTI Recent Developments
  43. 7.8 Frontage
  44. 7.8.1 Frontage Company Information
  45. 7.8.2 Frontage Business Overview
  46. 7.8.3 Frontage Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Frontage Pharmaceutical Safety Assessment Product Portfolio
  48. 7.8.5 Frontage Recent Developments
  49. 7.9 Medicilon
  50. 7.9.1 Medicilon Company Information
  51. 7.9.2 Medicilon Business Overview
  52. 7.9.3 Medicilon Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Medicilon Pharmaceutical Safety Assessment Product Portfolio
  54. 7.9.5 Medicilon Recent Developments
  55. 7.10 Wuxi Biologics
  56. 7.10.1 Wuxi Biologics Company Information
  57. 7.10.2 Wuxi Biologics Business Overview
  58. 7.10.3 Wuxi Biologics Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Wuxi Biologics Pharmaceutical Safety Assessment Product Portfolio
  60. 7.10.5 Wuxi Biologics Recent Developments
  61. 7.11 Pharmaron
  62. 7.11.1 Pharmaron Company Information
  63. 7.11.2 Pharmaron Business Overview
  64. 7.11.3 Pharmaron Pharmaceutical Safety Assessment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pharmaron Pharmaceutical Safety Assessment Product Portfolio
  66. 7.11.5 Pharmaron Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Safety Assessment Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Safety Assessment Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Safety Assessment Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Safety Assessment Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Safety Assessment Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Safety Assessment Revenue by Country
  11. 8.6.1 North America Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Safety Assessment Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Safety Assessment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Safety Assessment Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Safety Assessment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Safety Assessment Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Safety Assessment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Safety Assessment Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Safety Assessment Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Safety Assessment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Safety Assessment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Safety Assessment Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Safety Assessment Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Safety Assessment Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Safety Assessment Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Safety Assessment Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Safety Assessment Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Safety Assessment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Safety Assessment Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Safety Assessment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Safety Assessment Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Safety Assessment Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Safety Assessment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Safety Assessment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Safety Assessment Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Safety Assessment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Safety Assessment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Safety Assessment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Safety Assessment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Safety Assessment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Safety Assessment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Safety Assessment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Safety Assessment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Safety Assessment Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Safety Assessment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Safety Assessment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Safety Assessment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst